Reply to Letter to the Editor “The Effects of Resveratrol on Markers of Oxidative Stress in Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial”

Reply to Letter to the Editor “The Effects of Resveratrol on Markers of Oxidative Stress in Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial” Publisher Pubmed

Seyyedebrahimi S¹ ; Khodabandehloo H¹ ; Esfahani EN² ; Meshkani R^{1, 3}

Show Affiliations

1. Department of Clinical Biochemistry, Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran
2. Diabetes Research Center, Endocrinology & Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran
3. Endocrinology and Metabolism Research Center, Endocrinology & Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran

Source: Acta Diabetologica Published:2018

Abstract

[No abstract available]

Experts (# of related papers)

Ahmad Esmaillzadeh (1)

Bagher Larijani (1)

Style	Citing Format
MLA	Seyyedebrahimi S, et al.. "Reply to Letter to the Editor “The Effects of Resveratrol on Markers of Oxidative Stress in Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial”." Acta Diabetologica, vol. 55, no. 7, 2018, pp. 755-756.
APA	Seyyedebrahimi S, Khodabandehloo H, Esfahani EN, Meshkani R (2018). Reply to Letter to the Editor “The Effects of Resveratrol on Markers of Oxidative Stress in Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial”. Acta Diabetologica, 55(7), 755-756.
Chicago	Seyyedebrahimi S, Khodabandehloo H, Esfahani EN, Meshkani R. "Reply to Letter to the Editor “The Effects of Resveratrol on Markers of Oxidative Stress in Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial”." Acta Diabetologica 55, no. 7 (2018): 755-756.
Harvard	Seyyedebrahimi S et al. (2018) 'Reply to Letter to the Editor “The Effects of Resveratrol on Markers of Oxidative Stress in Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial”', Acta Diabetologica, 55(7), pp. 755-756.
Vancouver	Seyyedebrahimi S, Khodabandehloo H, Esfahani EN, Meshkani R. Reply to Letter to the Editor “The Effects of Resveratrol on Markers of Oxidative Stress in Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial”. Acta Diabetologica. 2018;55(7):755-756.
BibTex	@article{ author = {Seyyedebrahimi S and Khodabandehloo H and Esfahani EN and Meshkani R}, title = {Reply to Letter to the Editor “The Effects of Resveratrol on Markers of Oxidative Stress in Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial”}, journal = {Acta Diabetologica}, volume = {55}, number = {7}, pages = {755-756}, year = {2018} }
RIS	TY - JOUR AU - Seyyedebrahimi S AU - Khodabandehloo H AU - Esfahani EN AU - Meshkani R TI - Reply to Letter to the Editor “The Effects of Resveratrol on Markers of Oxidative Stress in Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial” JO - Acta Diabetologica VL - 55 IS - 7 SP - 755 EP - 756 PY - 2018 ER -

Science Communicator Platform

Authors

Authors Affiliations

Abstract